First Eagle Investment Management LLC Decreases Holdings in Danaher Corporation (DHR)
First Eagle Investment Management LLC decreased its position in Danaher Corporation (NYSE:DHR) by 46.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,568,751 shares of the conglomerate’s stock after selling 1,356,852 shares during the quarter. First Eagle Investment Management LLC owned approximately 0.23% of Danaher Corporation worth $134,567,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of DHR. Vanguard Group Inc. grew its stake in shares of Danaher Corporation by 1.3% in the second quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock worth $3,501,206,000 after acquiring an additional 520,776 shares during the last quarter. BlackRock Inc. grew its stake in shares of Danaher Corporation by 3.2% in the second quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock worth $3,308,239,000 after acquiring an additional 1,233,876 shares during the last quarter. FMR LLC grew its stake in shares of Danaher Corporation by 0.9% in the second quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock worth $1,656,100,000 after acquiring an additional 183,183 shares during the last quarter. Parnassus Investments CA grew its stake in shares of Danaher Corporation by 0.3% in the third quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after acquiring an additional 29,381 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Danaher Corporation by 6.0% in the first quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock worth $496,687,000 after acquiring an additional 329,458 shares during the last quarter. Institutional investors and hedge funds own 75.56% of the company’s stock.
In other Danaher Corporation news, insider William King sold 43,688 shares of the firm’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the transaction, the insider now directly owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Robert S. Lutz sold 11,189 shares of the firm’s stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $91.66, for a total value of $1,025,583.74. Following the completion of the transaction, the chief accounting officer now directly owns 18,314 shares in the company, valued at $1,678,661.24. The disclosure for this sale can be found here. Insiders sold 317,498 shares of company stock worth $28,838,801 over the last three months. Insiders own 12.20% of the company’s stock.
Danaher Corporation (NYSE DHR) traded up $0.13 during trading on Friday, hitting $93.89. The company had a trading volume of 222,517 shares, compared to its average volume of 2,652,275. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a 12 month low of $76.27 and a 12 month high of $94.24. The stock has a market capitalization of $65,219.94, a PE ratio of 24.10, a PEG ratio of 2.23 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the consensus estimate of $0.95 by $0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. During the same period last year, the firm posted $0.87 earnings per share. Danaher Corporation’s revenue was up 9.6% compared to the same quarter last year. research analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a $0.14 dividend. The ex-dividend date was Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.60%. Danaher Corporation’s payout ratio is 16.52%.
A number of equities research analysts have recently commented on DHR shares. J P Morgan Chase & Co reissued an “overweight” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, September 8th. Zacks Investment Research raised Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a research note on Thursday, October 5th. Morgan Stanley reaffirmed an “overweight” rating and set a $95.00 price objective (up from $86.00) on shares of Danaher Corporation in a research report on Friday, October 6th. Credit Suisse Group increased their price objective on Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Finally, Cowen Inc reaffirmed a “buy” rating and set a $90.00 price objective on shares of Danaher Corporation in a research report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $93.31.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.